This application relates to a compound of formula I (or a prodrug thereof or
a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined
herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor
Xa, as well as a process for its preparation and intermediates therefor.
